Dexter Schools USD #471 announced Monday that they dismissed school three days early for winter break due to widespread ...

Moderna MRNA announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has ...

COVID-19, RSV, and influenza immunizations show continued safety and substantial effectiveness against hospitalization across various populations.

The American Academy of Pediatrics has issued updated recommendations for RSV prevention in infants and high-risk young children.

Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.

NEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...

You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus the ...

It may feel like you are surrounded by sniffles and coughs, but flu season activity is still low in many parts of the U.S.

Dec 12 (Reuters) - GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) vaccine, Arexvy, for all adults above the age of 18, paving ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

Research led by the Veterans Affairs Portland Health Care System in Portland, Oregon, found that a single dose of respiratory syncytial virus (RSV) vaccine reduced RSV infections and RSV-related ...

The global respiratory syncytial virus vaccines market size was calculated at USD 3.55 billion in 2024 and is expected to grow steadily from USD 5.05 billion in 2025 to reach around USD 120.86 billion ...